• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Autonomix Medical, Inc. (AMIX)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date		2026-Mar-31	2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period		Q4-FY2026	Q3-FY2026	Q2-FY2026	Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024
Total Revenue			0$			0$	0$	0$	0$	0$	0$	0$	0$
QoQ%						.00%	.00%	.00%	.00%	.00%	.00%	.00%
YoY%			.00%			.00%	.00%	.00%	.00%
Cost Of Revenue			0$			0$	0$	0$	0$	0$	0$	0$	0$
Gross Profit			0$			0$	0$	0$	0$	0$	0$	0$	0$
Gross Margin
Operating Expenses		2,737,000$	3,343,000$	7,534,000$	3,421,000$	3,252,000$	2,747,000$	2,836,000$	2,753,000$	2,416,000$	2,924,000$	5,820,000$	871,000$	657,000$	544,000$
Operating Income		(2,737,000$)	(3,343,000$)	(7,534,000$)	(3,421,000$)	(3,252,000$)	(2,747,000$)	(2,836,000$)	(2,753,000$)	(2,416,000$)	(2,924,000$)	(5,820,000$)	(871,000$)	(657,000$)	(544,000$)
Operating Margin
Interest Income		71,000$	82,000$	83,000$	84,000$	107,000$	80,000$	72,000$	95,000$	80,000$	23,000$	19,000$	6,000$
Interest Expenses											33,000$
Income Before Tax		(2,666,000$)	(3,261,000$)	(7,451,000$)	(3,337,000$)	(3,191,000$)	(2,712,000$)	(2,807,000$)	(2,699,000$)	(5,408,000$)	(3,113,000$)	(6,040,000$)	(865,000$)	(657,000$)	(544,000$)
Tax Expenses						0$	0$	0$	0$		0$	0$	0$
Net Income		(2,666,000$)	(3,261,000$)	(7,450,000$)	(3,337,000$)	(11,410,000$)	(2,712,000$)	(2,807,000$)	(2,699,000$)	(15,426,000$)	(3,113,000$)	(6,040,000$)	(865,000$)	(657,000$)	(544,000$)
Profit Margin
TTM
Earnings to Minority
Earnings to Common Shareholders		(2,666,000$)	(3,261,000$)	(7,450,000$)	(3,337,000$)	(11,410,000$)	(2,712,000$)	(2,807,000$)	(2,699,000$)	(15,426,000$)	(3,113,000$)	(6,040,000$)	(865,000$)	(657,000$)	(544,000$)
QoQ%		18.25%	56.23%	(123.25%)	70.75%	(320.72%)	3.38%	(4.00%)	82.50%	(395.54%)	48.46%	(598.27%)	(31.66%)	(20.77%)
YoY%		76.64%	(20.24%)	(165.41%)	(23.64%)	26.03%	12.88%	53.53%	(212.02%)	(2,247.95%)	(472.24%)
Earnings Per Share, Basic		(0.23$)	(0.36$)	(1.38$)	(1.07$)	(4.14$)	(1.46$)	(2.27$)	(2.20$)	1.48$	(3.07$)	(8.78$)	(0.07$)		(0.05$)
Earnings Per Share, Diluted											(0.23$)				(0.05$)
Unlevered FCF Per Share, Basic		(0.25$)	(0.33$)	(0.71$)	(0.84$)	(3.00$)	(1.25$)	(1.29$)	(1.52$)	0.64$		(1.66$)	(0.05$)
Unlevered FCF Per Share, Diluted
Average Shares, Basic		11,394,354	8,955,809	5,411,709	3,105,156	2,754,062	1,851,910	1,234,305	1,225,423	-10,423,600	1,014,036	687,840	12,884,604		11,999,071
Average Shares, Diluted											13,799,170				11,999,071
EBIT		(2,666,000$)	(3,261,000$)	(7,451,000$)	(3,337,000$)	(3,191,000$)	(2,712,000$)	(2,807,000$)	(2,699,000$)	(5,408,000$)	(3,080,000$)	(6,040,000$)	(865,000$)	(657,000$)	(544,000$)
EBITDA		(2,663,000$)	(3,257,000$)	(7,449,000$)	(3,334,000$)	(3,008,000$)	(2,665,000$)	(2,762,000$)	(2,656,000$)	(5,327,000$)	(3,080,000$)	(6,040,000$)	(865,000$)	(657,000$)	(544,000$)

Copy Table ✓